Name | PQR530 |
---|---|
Synonyms |
CPD1536
PQR-530 4-(Difluoromethyl)-5-[4-[(3S)-3-methyl-4-morpholinyl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-2-pyridinamine |
Description | PQR-530 is a potent, oral and brain-penetrant dual pan-PI3K/mTORC1/2 inhibitor, exhibiting antitumor activity. |
---|---|
Related Catalog | |
Target |
PI3K mTORC1 mTORC2 |
In Vitro | PQR-530 is a potent, oral and brain-penetrant dual pan-PI3K/mTORC1/2 inhibitor, exhibiting antitumor activity. PQR-530 inhibits all PI3K isoforms and mTOR complexes C1/2 potently and selectively. PQR-530 inhibits protein kinase B (PKB, pSer473) and ribosomal protein S6 (pS6, pSer235/236) phosphorylation with IC50 values of 0.07 µM in A2058 melanoma cells. PQR-530 shows inhibitory activity against the growth of 44 cancer cell lines with mean GI50 of 426 nM[1]. |
References |
Density | 1.338±0.06 g/cm3 |
---|---|
Molecular Formula | C18H23F2N7O2 |
Molecular Weight | 407.42 |
Water Solubility | Practically insoluble (0.057 g/L) (25 ºC) |